217 related articles for article (PubMed ID: 37982363)
1. Hepatic Bile Acid Transporters and Drug-induced Hepatotoxicity.
Saran C; Brouwer KLR
Toxicol Pathol; 2023 Oct; 51(7-8):405-413. PubMed ID: 37982363
[TBL] [Abstract][Full Text] [Related]
2. Novel Bile Acid-Dependent Mechanisms of Hepatotoxicity Associated with Tyrosine Kinase Inhibitors.
Saran C; Sundqvist L; Ho H; Niskanen J; Honkakoski P; Brouwer KLR
J Pharmacol Exp Ther; 2022 Feb; 380(2):114-125. PubMed ID: 34794962
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Systems Toxicology Modeling Predicts that Reduced Biliary Efflux Contributes to Tolvaptan Hepatotoxicity.
Beaudoin JJ; Brock WJ; Watkins PB; Brouwer KLR
Clin Pharmacol Ther; 2021 Feb; 109(2):433-442. PubMed ID: 32748396
[TBL] [Abstract][Full Text] [Related]
4. Application of a Mechanistic Model to Evaluate Putative Mechanisms of Tolvaptan Drug-Induced Liver Injury and Identify Patient Susceptibility Factors.
Woodhead JL; Brock WJ; Roth SE; Shoaf SE; Brouwer KL; Church R; Grammatopoulos TN; Stiles L; Siler SQ; Howell BA; Mosedale M; Watkins PB; Shoda LK
Toxicol Sci; 2017 Jan; 155(1):61-74. PubMed ID: 27655350
[TBL] [Abstract][Full Text] [Related]
5. Role of Organic Solute Transporter Alpha/Beta in Hepatotoxic Bile Acid Transport and Drug Interactions.
Beaudoin JJ; Bezençon J; Sjöstedt N; Fallon JK; Brouwer KLR
Toxicol Sci; 2020 Jul; 176(1):34-35. PubMed ID: 32294204
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Evaluation of Bile Acid Homeostasis in Human Hepatocyte Co-Culture in the Presence of Troglitazone, Pioglitazone, and Acetylsalicylic Acid.
Chang JH; Sangaraju D; Liu N; Jaochico A; Plise E
Mol Pharm; 2019 Oct; 16(10):4230-4240. PubMed ID: 31509422
[TBL] [Abstract][Full Text] [Related]
7. Mechanism-based integrated assay systems for the prediction of drug-induced liver injury.
Kawaguchi M; Nukaga T; Sekine S; Takemura A; Susukida T; Oeda S; Kodama A; Hirota M; Kouzuki H; Ito K
Toxicol Appl Pharmacol; 2020 May; 394():114958. PubMed ID: 32198022
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Drug-Induced Liver Injury Prediction: Criteria Optimization of Efflux Transporter IC50 and Physicochemical Properties.
Yucha RW; He K; Shi Q; Cai L; Nakashita Y; Xia CQ; Liao M
Toxicol Sci; 2017 Jun; 157(2):487-499. PubMed ID: 28369588
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of bile salt transport by drugs associated with liver injury in primary hepatocytes from human, monkey, dog, rat, and mouse.
Zhang J; He K; Cai L; Chen YC; Yang Y; Shi Q; Woolf TF; Ge W; Guo L; Borlak J; Tong W
Chem Biol Interact; 2016 Aug; 255():45-54. PubMed ID: 27000539
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Human Hepatic Bile Acid Transporters by Tolvaptan and Metabolites: Contributing Factors to Drug-Induced Liver Injury?
Slizgi JR; Lu Y; Brouwer KR; St Claire RL; Freeman KM; Pan M; Brock WJ; Brouwer KL
Toxicol Sci; 2016 Jan; 149(1):237-50. PubMed ID: 26507107
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone Inhibits Bile Acid Amidation: A Possible Risk Factor for Liver Injury.
Ogimura E; Nakagawa T; Deguchi J; Sekine S; Ito K; Bando K
Toxicol Sci; 2017 Aug; 158(2):347-355. PubMed ID: 28486596
[TBL] [Abstract][Full Text] [Related]
12. In vitro assessment of farnesoid X receptor antagonism to predict drug-induced liver injury risk.
Norona LM; Fullerton A; Lawson C; Leung L; Brumm J; Kiyota T; Maher J; Khojasteh C; Proctor WR
Arch Toxicol; 2020 Sep; 94(9):3185-3200. PubMed ID: 32583097
[TBL] [Abstract][Full Text] [Related]
13. Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes.
Ogimura E; Sekine S; Horie T
Biochem Biophys Res Commun; 2011 Dec; 416(3-4):313-7. PubMed ID: 22108051
[TBL] [Abstract][Full Text] [Related]
14. Systems pharmacology modeling predicts delayed presentation and species differences in bile acid-mediated troglitazone hepatotoxicity.
Yang K; Woodhead JL; Watkins PB; Howell BA; Brouwer KL
Clin Pharmacol Ther; 2014 Nov; 96(5):589-98. PubMed ID: 25068506
[TBL] [Abstract][Full Text] [Related]
15. Quantitative NTCP pharmacophore and lack of association between DILI and NTCP Inhibition.
Dong Z; Ekins S; Polli JE
Eur J Pharm Sci; 2015 Jan; 66():1-9. PubMed ID: 25220493
[TBL] [Abstract][Full Text] [Related]
16. Use of sandwich-cultured hepatocytes to evaluate impaired bile acid transport as a mechanism of drug-induced hepatotoxicity.
Marion TL; Leslie EM; Brouwer KL
Mol Pharm; 2007; 4(6):911-8. PubMed ID: 17963355
[TBL] [Abstract][Full Text] [Related]
17. Current challenges and controversies in drug-induced liver injury.
Corsini A; Ganey P; Ju C; Kaplowitz N; Pessayre D; Roth R; Watkins PB; Albassam M; Liu B; Stancic S; Suter L; Bortolini M
Drug Saf; 2012 Dec; 35(12):1099-117. PubMed ID: 23137150
[TBL] [Abstract][Full Text] [Related]
18. Quantitative targeted bile acid profiling as new markers for DILI in a model of methapyrilene-induced liver injury in rats.
Slopianka M; Herrmann A; Pavkovic M; Ellinger-Ziegelbauer H; Ernst R; Mally A; Keck M; Riefke B
Toxicology; 2017 Jul; 386():1-10. PubMed ID: 28529062
[TBL] [Abstract][Full Text] [Related]
19. Polygonum multiflorum Thunb. Induces hepatotoxicity in SD rats and hepatocyte spheroids by Disrupting the metabolism of bilirubin and bile acid.
Wang Q; Wen H; Ma S; Zhang Y
J Ethnopharmacol; 2022 Oct; 296():115461. PubMed ID: 35728710
[TBL] [Abstract][Full Text] [Related]
20. Perturbation of bile acid homeostasis is an early pathogenesis event of drug induced liver injury in rats.
Yamazaki M; Miyake M; Sato H; Masutomi N; Tsutsui N; Adam KP; Alexander DC; Lawton KA; Milburn MV; Ryals JA; Wulff JE; Guo L
Toxicol Appl Pharmacol; 2013 Apr; 268(1):79-89. PubMed ID: 23360887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
